However, technical errors in the synthesis of oligonucleotides (short DNA sequences)—particularly in droplet-based methods ...
TXG's new lower-cost Chromium offerings could drive volume growth ... a conservative but optimistic outlook. Founded in 2012, 10x Genomics (NASDAQ:TXG) is a biotech company developing gene ...
10x Genomics, Inc., a life science technology ... and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic ...
Building on a record year of Chromium product releases in 2024, 10x Genomics announced plans to enable high-performance, mega-scale single cell analysis with improved efficiency and ease of use.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results